MedPath

Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia

Completed
Conditions
Human Papillomavirus Infection
Cervical Intraepithelial Neoplasia
Registration Number
NCT00931190
Lead Sponsor
Lund University
Brief Summary

The objectives are to evaluate the effectiveness of treatment of cervical intraepithelial neoplasia (CIN) by loop electrosurgical excision procedure using persistence of human papillomavirus (HPV) as outcome, and to perform a long-term follow-up on the ability of HPV testing, as compared to cytology, to predict recurrence of high-grade CIN.

Detailed Description

Cervical samples for human papillomavirus (HPV) DNA analysis and cytological analysis were obtained from women with abnormal smears referred to Umeå university hospital, Sweden, for treatment with conization. These women were scheduled for HPV DNA testing and Pap smears before and 3, 6, 12, 24 and 36 months after treatment. The HPV DNA testing was performed with a PCR-based genotyping method.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
195
Inclusion Criteria
  • Referral to Umeå university hospital for treatment due to abnormal Pap smear.
Exclusion Criteria
  • Lack of informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dept. obstetrics and gynecology, University hospital of Northern Sweden

🇸🇪

Umeå, Sweden

© Copyright 2025. All Rights Reserved by MedPath